# Immunoglobulin Dosage and Administration Form in CIDP and MMN

> **NCT02111590** · — · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 36 (actual)

## Conditions studied

- Chronic Inflammatory Demyelinating Polyneuropathy
- Multifocal Motor Neuropathy
- Hemolytic Anemia

## Interventions

- **DRUG:** Immunoglobulins

## Key facts

- **NCT ID:** NCT02111590
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-09-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02111590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02111590, "Immunoglobulin Dosage and Administration Form in CIDP and MMN". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02111590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*